BCMA-CD19 cCAR T Cell Treatment of Relapsed/Refractory Systemic Lupus Erythematosus (SLE)

NCT05474885 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed/Refractory, Systemic Lupus Erythematosus (SLE)

Interventions

BIOLOGICAL: BCMA-CD19 cCAR T cells

Sponsor

iCell Gene Therapeutics

Collaborators

[object Object]